Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Conte

Showing results (321-330 of 338) with videos related to

Pageof 34
Sort By:
Bulletin Du Cancer|January 22, 1998
[Intensive chemotherapy with autologous stem cell transplantation in ovarian cancers: analysis of 67 patients treated at the Paoli-Calmettes Institute and a review of the literature]P Viens, F Bertucci, G Gravis, et al.
International Journal of Molecular Sciences|March 27, 2025
Induced Types 2 and 3 Deiodinase in Non-Thyroidal Illness Syndrome and the Implications to Critical Illness-Induced Myopathy-A Prospective Cohort StudyAndré Cardoso Braun, Thaliane Carvalho Oliveira, Ludmilla C D Thomazini, et al.
Mbio|October 16, 2014
Detection of zoonotic pathogens and characterization of novel viruses carried by commensal Rattus norvegicus in New York CityCadhla Firth, Meera Bhat, Matthew A Firth, et al.
Pediatric Blood & Cancer|April 28, 2017
Malignant ovarian germ cell tumors in pediatric patients: The AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica) studyM Terenziani, G Bisogno, R Boldrini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
Resection of primary tumor at diagnosis in stage IV-S neuroblastoma: does it affect the clinical course?M Guglielmi, B De Bernardi, A Rizzo, et al.
The Journal of Clinical Endocrinology and Metabolism|March 1, 1996
Comparative study of alendronate versus etidronate for the treatment of Paget's disease of boneE Siris, R S Weinstein, R Altman, et al.
Transfusion|February 28, 2025
An assessment of laboratory changes during autologous whole blood transfusion training: A prospective, observational studySteven G Schauer, Juliette M Conte, Ian L Hudson, et al.
British Journal of Cancer|September 4, 2008
Treatment of localised resectable neuroblastoma. Results of the LNESG1 study by the SIOP Europe Neuroblastoma GroupB De Bernardi, V Mosseri, H Rubie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
MYCN oncogene amplification in neuroblastoma is associated with worse prognosis, except in stage 4s: the Italian experience with 295 childrenG P Tonini, L Boni, A Pession, et al.
Journal of Hematology & Oncology|February 22, 2026
UVI5008: the first reversible, non-covalent Bruton's tyrosine kinase epi-inhibitor for B-cell malignanciesCarmela Dell'Aversana, G Sgueglia, C Massaro, et al.
Pageof 34

Showing results (321-330 of 338) with videos related to

Sort By:
Pageof 34
Bulletin Du Cancer|January 22, 1998
[Intensive chemotherapy with autologous stem cell transplantation in ovarian cancers: analysis of 67 patients treated at the Paoli-Calmettes Institute and a review of the literature]P Viens, F Bertucci, G Gravis, et al.
International Journal of Molecular Sciences|March 27, 2025
Induced Types 2 and 3 Deiodinase in Non-Thyroidal Illness Syndrome and the Implications to Critical Illness-Induced Myopathy-A Prospective Cohort StudyAndré Cardoso Braun, Thaliane Carvalho Oliveira, Ludmilla C D Thomazini, et al.
Mbio|October 16, 2014
Detection of zoonotic pathogens and characterization of novel viruses carried by commensal Rattus norvegicus in New York CityCadhla Firth, Meera Bhat, Matthew A Firth, et al.
Pediatric Blood & Cancer|April 28, 2017
Malignant ovarian germ cell tumors in pediatric patients: The AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica) studyM Terenziani, G Bisogno, R Boldrini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
Resection of primary tumor at diagnosis in stage IV-S neuroblastoma: does it affect the clinical course?M Guglielmi, B De Bernardi, A Rizzo, et al.
The Journal of Clinical Endocrinology and Metabolism|March 1, 1996
Comparative study of alendronate versus etidronate for the treatment of Paget's disease of boneE Siris, R S Weinstein, R Altman, et al.
Transfusion|February 28, 2025
An assessment of laboratory changes during autologous whole blood transfusion training: A prospective, observational studySteven G Schauer, Juliette M Conte, Ian L Hudson, et al.
British Journal of Cancer|September 4, 2008
Treatment of localised resectable neuroblastoma. Results of the LNESG1 study by the SIOP Europe Neuroblastoma GroupB De Bernardi, V Mosseri, H Rubie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
MYCN oncogene amplification in neuroblastoma is associated with worse prognosis, except in stage 4s: the Italian experience with 295 childrenG P Tonini, L Boni, A Pession, et al.
Journal of Hematology & Oncology|February 22, 2026
UVI5008: the first reversible, non-covalent Bruton's tyrosine kinase epi-inhibitor for B-cell malignanciesCarmela Dell'Aversana, G Sgueglia, C Massaro, et al.
Pageof 34